Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Interoperability and decentralization have been major themes in tech this year, driven in large part by mounting regulation, societal and industrial pressure and the hype trains that are crypto and ...
(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday progress on its collaboration and license agreement (CLA) with Sanofi SA (SNY) regarding Novavax's Matrix-M adjuvant. The companies have amended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results